Randomized phase 2 trial comparing amrubicin (A) with re-challenge of platinum doublet (P) in patients (pts) with sensitive-relapsed small-cell lung cancer (SCLC).
Atsushi Nakamura
No relevant relationships to disclose
Akira Inoue
No relevant relationships to disclose
Makoto Maemondo
No relevant relationships to disclose
Yoshiaki Mori
No relevant relationships to disclose
Satoshi Oizumi
No relevant relationships to disclose
Masao Harada
No relevant relationships to disclose
Shingo Takanashi
No relevant relationships to disclose
Naoto Morikawa
No relevant relationships to disclose
Takashi Ishida
No relevant relationships to disclose
Ichiro Kinoshita
No relevant relationships to disclose
Hiroshi Watanabe
No relevant relationships to disclose
Toshiro Suzuki
No relevant relationships to disclose
Taku Nakagawa
No relevant relationships to disclose
Ryota Saito
No relevant relationships to disclose
Toshihiro Nukiwa
No relevant relationships to disclose